Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...

While PH Awareness Month is a great opportunity to connect and educate, rare disease advocacy is columnist Jen Cueva's passion all year.

The Pulmonary Hypertension Association (PHA) is fundraising and advocating this awareness month with a "Let Your Light Shine" ...

Supervised pulmonary rehabilitation exercises help severe PAH lung transplant candidates maintain or improve exercise ...

Children with PH are more likely to be active if physical activity is fun, allows them to be with friends, and is inclusive, ...

Abnormalities in levels of microRNAs, affecting protein production, may tie to CTEPH development and progression; possible ...

Researchers at Monash University in Australia will use newly granted funding to advance their work on a project that aims to create a novel disease-modifying treatment for pulmonary arterial ...

An upcoming clinical trial will test whether empagliflozin, a drug widely approved to treat diabetes and heart failure, might be able to improve heart health in people with pulmonary arterial ...

“The flower that blooms in adversity is the most rare and beautiful of all.” — Disney’s “Mulan” Being diagnosed with pulmonary hypertension (PH) is a daunting experience, like stepping into uncharted ...